Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

Clinical trial NCT04977167 · UNKNOWN

Trial details

NCT number: NCT04977167
Sponsor: HitGen Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Lymphoma

Start date: 2023-07-28
Primary completion: 2024-12-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.